Where does Surgery Partners, Inc.'s cash flow data come from?

Every line is extracted from Surgery Partners, Inc.'s SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.

	FY'25	FY'24	FY'23	FY'22
Net income	$98.9M+300%	-$49.4M-137%	$135.3M+55.5%	$87M+23.1%
Depreciation and amortization	$176M+15.3%	$152.6M+29.2%	$118.1M+2.9%	$114.8M+16.2%
Stock-based compensation	——	$33.3M+88.1%	$17.7M-3.8%	$18.4M+5.7%
Deferred income taxes	$16.7M-87.3%	$131.5M—	——	$21.9M+146%
Change in accounts receivable	$53.8M-25.4%	$72.1M+52.8%	$47.2M+33.7%	$35.3M+10.0%
Other working capital changes	——	——	$16.3M-75.7%	$67M+54.4%
Distributions from equity method investments	$800K-60.0%	$2M—	——	——
Net cash from operating activities	$274.3M-8.6%	$300.1M+2.1%	$293.8M+85.0%	$158.8M+82.3%
Capital expenditures	$78.7M-12.9%	$90.4M+1.8%	$88.8M+10.2%	$80.6M+39.9%
Acquisitions, net of cash acquired	$162.1M-57.2%	$378.8M+374%	$80M-45.4%	$146.4M-48.8%
Proceeds from sale of businesses	$46.5M—	——	——	$12.9M+115%
Other investing activities	$40.5M+63.3%	$24.8M-26.4%	$33.7M—	——
Purchases of equity securities	——	——	$50.3M-47.1%	$95.1M—
Proceeds from sales of equity securities	$1.5M—	——	$1.4M—	——
Net cash from investing activities	-$248.7M+49.1%	-$488.5M-117%	-$225.6M+26.7%	-$307.9M+7.2%
Proceeds from issuance of debt	$1.2B-30.5%	$1.73B+109%	$826.6M+280%	$217.8M-27.3%
Repayments of debt	$1.04B-18.7%	$1.28B+58.5%	$807.1M-6.4%	$862M+151%
Distributions to noncontrolling interests	$226M+32.6%	$170.5M+16.7%	$146.1M-0.5%	$146.8M+12.1%
Other financing activities	$9.4M+175%	-$12.6M-0.8%	-$12.5M-26.3%	-$9.9M+44.7%
Payment of debt issuance costs	$4.1M-72.8%	$15.1M-37.9%	$24.3M—	$0-100%
Net cash from financing activities	——	$269.3M+274%	-$155.2M-469%	$42.1M—
Net increase (decrease) in cash	——	$73.6M—	——	——
Interest paid	$256.8M+28.6%	$199.7M+17.7%	$169.6M-22.5%	$218.7M+12.6%
Income taxes paid	$1.2M-25.0%	$1.6M+14.3%	$1.4M-22.2%	$1.8M+20.0%
Gain (Loss) On Disposition Of Assets And Deconsolidation	-$30.4M+25.1%	-$40.6M-182%	-$14.4M-29.7%	-$11.1M-405%
Income Loss From Equity Method Investments Net Of Dividends Or Distributions	$800K-60.0%	$2M—	——	——
Noncash Interest Income (Expense), Net	-$9.6M-47.7%	-$6.5M+74.0%	-$25M+3.5%	-$25.9M-17.7%
Payment for (Proceeds from) Other Investing Activity	$40.5M+63.3%	$24.8M-26.4%	$33.7M—	——
Payments to Acquire Equity Method Investments	——	——	$50.3M-47.1%	$95.1M—
Sales of and distributions from equity method investments	$1.5M—	——	$1.4M—	——
Proceeds from disposition of property, plant and equipment/other	$46.5M—	——	——	$12.9M+115%
Payments Of Debt Issuance Costs	$4.1M-72.8%	$15.1M-37.9%	$24.3M—	$0-100%
Other, net	$9.4M+175%	-$12.6M-0.8%	-$12.5M-26.3%	-$9.9M+44.7%
Proceeds From Payments To Minority Shareholders	——	$10M—	——	——
Operating Lease Expense	$37.8M-2.8%	$38.9M+10.5%	$35.2M+1.1%	$34.8M-11.0%
Income Taxes Paid, Net	$1.2M-25.0%	$1.6M+14.3%	$1.4M-22.2%	$1.8M+20.0%
Free cash flow	$195.6M-6.7%	$209.7M+2.3%	$205M—	——
Free cash flow	$195.6M-6.7%	$209.7M+2.3%	$205M—	——

Chart any of these lines over time, or line them up against competitors.

Compare these in charts →

Questions, answered.

Where does Surgery Partners, Inc.'s cash flow data come from?: Every line is extracted from Surgery Partners, Inc.'s SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.